1. IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease
- Author
-
Dwyer, Gaelen K., Mathews, Lisa R., Villegas, Jose A., Lucas, Anna, de Peredo, Anne Gonzalez, Blazar, Bruce R., Girard, Jean-Philippe, Poholek, Amanda C., Luther, Sanjiv A., Shlomchik, Warren, and Turnquist, Heth R.
- Subjects
Immunological research ,T cells -- Health aspects -- Physiological aspects ,Stem cells -- Health aspects -- Physiological aspects ,Graft versus host reaction -- Care and treatment -- Development and progression ,Hematopoietic stem cells -- Transplantation ,Cellular signal transduction -- Research ,Interleukins -- Health aspects -- Physiological aspects ,Antigen presenting cells -- Health aspects -- Physiological aspects ,Health care industry - Abstract
Antigen-presenting cells (APCs) integrate signals emanating from local pathology and program appropriate T cell responses. In allogeneic hematopoietic stem cell transplantation (alloHCT), recipient conditioning releases damage-associated molecular patterns (DAMPs) that generate proinflammatory APCs that secrete IL-12, which is a driver of donor Th1 responses, causing graft-versus-host disease (GVHD). Nevertheless, other mechanisms exist to initiate alloreactive T cell responses, as recipients with disrupted DAMP signaling or lacking IL-12 develop GVHD. We established that tissue damage signals are perceived directly by donor [CD4.sup.+] T cells and promoted T cell expansion and differentiation. Specifically, the fibroblastic reticular cell-derived DAMP IL-33 is increased by recipient conditioning and is critical for the initial activation, proliferation, and differentiation of alloreactive Th1 cells. IL-33 stimulation of [CD4.sup.+] T cells was not required for lymphopenia-induced expansion, however. IL-33 promoted IL-12-independent expression of Tbet and generation of Th1 cells that infiltrated GVHD target tissues. Mechanistically, IL-33 augmented [CD4.sup.+] T cell TCR-associated signaling pathways in response to alloantigen. This enhanced T cell expansion and Th1 polarization, but inhibited the expression of regulatory molecules such as IL-10 and Foxp3. These data establish an unappreciated role for IL-33 as a costimulatory signal for donor Th1 generation after alloHCT., Introduction Allogeneic hematopoietic stem cell transplantation (alloHCT) is a curative therapy for high-risk hematopoietic malignancies and is also used to correct life-threatening lymphohematopoietic disorders. alloHCT has also shown promise as [...]
- Published
- 2022
- Full Text
- View/download PDF